CClinicalTrials.gg
CompletedNCT03001752ETPEI-RCTUpdated Jan 17, 2019

Immediate Implants Inserted Through Open Flap, Open Flap and Bone Grafting and Flapless Techniques

An interventional study of Open flap immediate implant and Open flap immediate implant and bone grafting in Isolated Premolar Edentulous Site, sponsored by University of Bari. Completed. Open to participants aged 20 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-01-17.

Sponsored by University of Bari · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Randomized
Ages
20 Years to 70 Years
Sex
All
01

Study summary

This is a three-armed randomized controlled clinical trial aiming the estimation of dimensional alveolar bone changes after insertion of post-extraction implants through 3 different surgical techniques: open flap, open flap and grafting, flapless.

Read the detailed description

Background and Objectives A recent systematic review investigating dimensional alveolar bone changes after insertion of post-extraction implants reported that there is a lack of randomized controlled trials that would serve as a scientific base for building clinical guidelines on alveolar site treatment after insertion of post-extraction implants. Different studies suggest that insertion of post-extraction implants should be performed after fully elevating a flap and inserting bone graft in the residual space between the implant surface and the alveolar socket. Other investigations report insignificant differences between open flap and flapless approaches, whereas the insertion of bone grafts remains controversial.

The present study is a three-armed randomized clinical controlled trial conducted with the following objectives:

  1. Evaluation of morphological and alveolar bone level differences (marginal bone loss) on post-extraction implants inserted with the following techniques: 1) open flap surgery alone; 2) open flap surgery and bone grafting; 3) flapless.
  2. Estimation of effectiveness of the three surgical techniques through measurement of secondary outcomes such as intra-operatory and post-operatory complications, pain and discomfort, time and costs.

Materials and Methods

  • This is a three-armed randomized controlled clinical trial where each arm will belong to one of the treatments: 1) open flap surgery alone; 2) open flap surgery and bone grafting; 3) flapless.
  • The randomizing sequence will be generated from a computer program (STATA 13) by a statistician who will also conduct blind statistical analysis of results.
  • All patients will be recruited prior to trial commencement. They will be extensively informed regarding the intervention and will sign a treatment consent.
  • Patients will be recruited according to the following inclusion criteria: absence of any systemic disease that might compromise implant integration or wound healing, appropriate periodontal health (measured through periodontal indexes), presence of premolars with indications of extractions, presence of adjacent teeth, absence of fenestrations, presence of vestibular alveolar wall with a minimum of 0.5mm of thickness. Patients who have undergone CT scanning in the past 5 years and heavy smokers (more than 20 cigarettes per day) will not be included in the study.
  • Calculation of sample size has already been performed by an experienced statistician, accounting for a minimal predicted difference between groups of 1mm (SD 0.75mm) of marginal bone loss, alpha error of 0.05 and 90% of power. Based on these calculations, a total of 45 patients will be included in the study.
  • Interventions will be performed in accordance with ethical standards as suggested by the Helsinki Declaration (1975). Approval of Ethical Committee of the University of Bari has already been obtained (reg.nr. 4987).
  • All surgical interventions will be performed by the same experienced surgeon who will be informed of the type of intervention after tooth extraction (allocation concealment through dark sealed envelopes).
  • The primary outcome is marginal bone loss (MBL) and alveolar bone dimensional changes measured through CT Cone Beam performed immediately after implant insertion and 6 months after. Secondary outcomes are intra-and post-operative complications, pain and discomfort, time and costs.
  • Outcomes will be measured by another clinician blinded in terms of treatment allocation.
  • Statistical analysis will be performed by an independent statistician. Statistical tests will include: One-way Anova, Bonferroni tests and several linear and logistic regressions in order to estimate potential predictive variables. Statistical significance will be set at .05.
  • Interruption of study will be considered in the following situations: 1.preliminary observation of highly significant difference between techniques indicating one technique highly superior; 2. big number of lost to follow-up (bigger than that considered during sample size calculation)
  • Patients will be excluded from the study in the following cases: missing follow-up hygiene controls at 1 and 3 months post-intervention, missing 6 months follow-up control, poor cooperation in terms of domestic oral hygiene (periodontal indexes measured), income of systemic or local diseases that might compromise outcomes.
02

Conditions studied

  • Isolated Premolar Edentulous Site

Browse trials for

Keywords

  • post-extraction dental implant
  • immediate dental implant
  • open flap
  • flapless
  • bone grafting
  • CT Cone Beam
03

In context

Mouth, Edentulous

244 studies on the registry are indexed under Mouth, Edentulous; 37 are open to participants now.

This study's enrollment of 45 is above the median of 30 across 187 interventional studies indexed under Mouth, Edentulous.

Browse Mouth, Edentulous studies →

Lead sponsor

University of Bari is the lead sponsor of 75 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • absence of any systemic disease that might compromise implant integration or wound healing
  • appropriate periodontal health (measured through periodontal indexes)
  • presence of premolars with indications of extractions, presence of adjacent teeth
  • absence of fenestrations
  • presence of vestibular alveolar wall with a minimum of 0.5mm of thickness

Exclusion criteria

Exclusion Criteria:

  • patients who have undergone CT scanning in the past 5 years
  • heavy smokers (more than 20 cigarettes per day)
  • patients not showing up at 1 and 3 months hygiene sessions
  • patients not showing up at 6 months follow-up
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
45 participants (actual)

Study arms

  • Active comparator
    Open flap immediate implant

    Open flap immediate implant insertion, without bone grafting

    Device: Open flap immediate implant

  • Active comparator
    Open flap immediate implant and bone grafting

    Open flap immediate implant insertion and bone grafting

    Device: Open flap immediate implant and bone grafting

  • Active comparator
    Flapless immediate implant

    Immediate implant insertion without opening flap of inserting bone grafting

    Device: Flapless immediate implant

Interventions

  • DeviceOpen flap immediate implant

    Post-extraction implants will be inserted through open flap, without bone grafting

    Also known as: Dental implant

  • DeviceOpen flap immediate implant and bone grafting

    Post-extraction implants will be inserted through open flap, adding bone grafting

    Also known as: Dental implant, bone grafting

  • DeviceFlapless immediate implant

    Post-extraction implants will be inserted without elevating flap or inserting bone grafting

06

What researchers measure

Primary outcomes

  1. Marginal Bone Loss measured through CT Cone Beam

    Difference of marginal bone level measured immediately after treatment and 6 months after on two repeated (immediately after and 6 months after implant insertion) CT Cone Beam

    Time frame: 6 months

  2. Alveolar Bone Dimensional Reduction assessed through CT Cone Beam

    Three-dimensional Alveolar Bone Reduction (horizontal and vertical) will be measured on two repeated (immediately after and 6 months after implant insertion) on CT Cone Beam, having as reference points the implant platform and the implant apex.

    Time frame: 6 months

Secondary outcomes

  1. Pain and Discomfort measured through questionaire

    Pain and discomfort experienced by the patient after the surgery, measured through a VAS scale on a questionaire

    Time frame: 1 Week

  2. Intra-operatory or post-operatory complications assessed through intra-operatory observation and post-intervention check-ups.

    Intra-operatory or post-operatory intervention-related adverse events such as excessive bleeding, swallowing, hematoma will be recorded for each patient.

    Time frame: 6 months

  3. Time needed to perform surgical intervention

    Time needed to perform surgical intervention (immediately after tooth extraction until finishing of surgical procedure) will be recorded for each intervention.

    Time frame: 1-2 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Lee CT, Chiu TS, Chuang SK, Tarnow D, Stoupel J. Alterations of the bone dimension following immediate implant placement into extraction socket: systematic review and meta-analysis. J Clin Periodontol. 2014 Sep;41(9):914-26. doi: 10.1111/jcpe.12276. Epub 2014 Jul 23. PubMed 24894299 ↗
  • Tarnow DP, Chu SJ. Human histologic verification of osseointegration of an immediate implant placed into a fresh extraction socket with excessive gap distance without primary flap closure, graft, or membrane: a case report. Int J Periodontics Restorative Dent. 2011 Sep-Oct;31(5):515-21. PubMed 21845246 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03001752
Lead sponsor
University of Bari
Responsible party
Felice Roberto Grassi (Professor, University of Bari) — Principal investigator
First posted
Dec 23, 2016
Start date
Jan 2017
Primary completion
Aug 2018
Completion
Nov 2018
Last update
Jan 17, 2019

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion